Quick Answer
CME GROUP INC. reported Diluted EPS of $11.16 per share for fiscal year 2025.
CME GROUP INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $11.16 | +15.4% |
| 2024 | $9.67 | +9.1% |
| 2023 | $8.86 | +19.7% |
| 2022 | $7.40 | +1.5% |
| 2021 | $7.29 | +24.2% |
| 2020 | $5.87 | -0.7% |
| 2019 | $5.91 | +3.5% |
| 2018 | $5.71 | -52.2% |
| 2017 | $11.94 | +163.6% |
| 2016 | $4.53 | +22.8% |
| 2015 | $3.69 | +10.1% |
| 2014 | $3.35 | +14.7% |
| 2013 | $2.92 | +8.1% |
| 2012 | $2.70 | -50.3% |
| 2011 | $5.43 | +89.9% |
| 2010 | $2.86 | -77.0% |
| 2009 | $12.41 | +2.3% |
| 2008 | $12.13 | -18.8% |
| 2007 | $14.93 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.49 | -0.4% | -11.4% |
| June 30, 2025 | $2.81 | +16.1% | +7.3% |
| March 31, 2025 | $2.62 | +11.5% | +4.8% |
| September 30, 2024 | $2.50 | +21.4% | +3.3% |
| June 30, 2024 | $2.42 | +13.1% | +3.0% |
| March 31, 2024 | $2.35 | -3.3% | +14.1% |
| September 30, 2023 | $2.06 | +10.2% | -3.7% |
| June 30, 2023 | $2.14 | +17.6% | -11.9% |
- CME GROUP INC. showed an increase of +15.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2007–2025 period, CME GROUP INC.’s diluted eps has declined by 25.3% (from $14.93 per share to $11.16 per share).
- The most recent figure is from CME GROUP INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: